Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Interest & Investment Income (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Interest & Investment Income for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 4.06% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.1 million, a 23.69% increase, with the full-year FY2025 number at $12.1 million, up 23.69% from a year prior.
  • Interest & Investment Income was $2.3 million for Q4 2025 at PROCEPT BioRobotics, down from $2.7 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $3.6 million in Q1 2025 to a low of -$77000.0 in Q4 2021.
  • A 5-year average of $1.6 million and a median of $1.7 million in 2023 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: crashed 328.57% in 2022, then soared 1398.33% in 2023.
  • PROCEPT BioRobotics' Interest & Investment Income stood at -$77000.0 in 2021, then skyrocketed by 1388.31% to $992000.0 in 2022, then surged by 228.43% to $3.3 million in 2023, then plummeted by 32.75% to $2.2 million in 2024, then rose by 4.06% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Interest & Investment Income are $2.3 million (Q4 2025), $2.7 million (Q3 2025), and $3.5 million (Q2 2025).